The US Food and Drug Administration (FDA) today approved a new autoinjection option for adalimumab-adbm (Cyltezo), a biosimilar to AbbVie's adalimumab (Humira), ahead of Cyltezo's commercial launch on ...
Humira (adalimumab) is a prescription drug used to treat hidradenitis suppurativa (HS). It helps reduce moderate to severe symptoms of this condition. Humira is also available in biosimilar forms.
Please provide your email address to receive an email when new articles are posted on . Five patients achieved Hidradenitis Suppurativa Clinical Response with 80 mg weekly adalimumab, whereas two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results